Govt approves Bharat Biotech’s plant for Covaxin production

The approval would help increase availability of C-19 vaccines in the country


Last Updated on August 12, 2021 by The Health Master

Union minister Mansukh Mandaviya yesterday said that the government has given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to produce C-19 vaccine Covaxin. “Govt of India approves vaccine manufacturing facility for production of @BharatBiotech’s #Covaxin in Ankleshwar, Gujarat,” Mandaviya tweeted.

The approval would help increase availability of C-19 vaccines in the country, he added.

“Following PM @NarendraModi ji’s vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world’s largest vaccine drive,” the minister who heads both Chemicals and Fertilisers and Health ministries, noted.

In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its Ankleshwar-based facility.

The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit – Chiron Behring, to add another 200 million doses of Covaxin.



Why to include Peptides in your Skincare Products ?

India and Pharmacy Education: Chapter: 4

Govt amends Rule 90 of D&C Rules for Form 29

Govt amends environment protection rules for Mfg of Bulk Drugs

NPPA caps on trade margin of 42 Non Scheduled Cancer Drugs

Govt fixes export quota for Covid Test Kits

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner